Cinoctramide

This classification denotes an anesthetic agent with the molecular formula C19H27NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 69J8AO72Q3, chemically known as octahydro-1-(3,4,5-trimethoxycinnamoyl)azocine. but generally known as cinoctramide, which bears US NIH Compound Identifier 6443803. European Medicines Agency schedules Cinoctramide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06306MIG. The term CINOCTRAMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 28, No. 10 1974, List 14). CINOCTRAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cinoctramide under HS 29339990 and SITC 51577. As of Q4 2014, CINOCTRAMIDE remains the US FDA Preferred Term for this commodity. Cinoctramide bears US NLM identifiers UMLS ID C2825618 and NCI Concept Code C81403. SMILES: O=C(N1CCCCCCC1)/C=C/C1CC(OC)C(OC)C(OC)C1.